Kvika banki hf.: Transaction in relation to a share buyback programme
In week 32 Kvika banki hf. („Kvika“ or „the bank“) purchased 4,500,000 of its own shares at the purchase price 68,312,500 ISK. See further details below:
| Date | Time | No. of shares purchased | Share price (rate) | Purchase price |
| 6.8.2024 | 10:01:55 | 1,000,000 | 15.050 | 15,050,000 |
| 7.8.2024 | 14:47:14 | 2,500,000 | 15.225 | 38,062,500 |
| 9.8.2024 | 11:40:50 | 1,000,000 | 15.200 | 15,200,000 |
| Total | 4,500,000 | 68,312,500 |
The trade is in accordance with Kvika‘s buyback programme. announced on 4 July 2024 and based on the authorisation of a shareholders‘ meeting of Kvika held on 21 March 2024.
Kvika held 18,631,783 own shares prior to the notified transaction and has thus purchased a total of 23,131,783 shares under the buyback programme, which corresponds to 0.490% of issued shares in the company. Total purchase price is 348,653,307 ISK. Buyback under the programme will amount to a maximum purchase price of 1,000,000,000 ISK.
The buyback programme is in effect from 4 July 2024 until Kvika‘s annual general meeting 2025. unless the maximum purchase price will be reached before that time.
The execution of the buy-back programme must comply with Act on Public Limited Companies. No. 2/1995. In addition. the buy-back programme must be implemented as provided for in the Regulation of the European Parliament and of the Council no. 596/2014. on market abuse. as well as the Commission Delegated Regulation (EU) 2016/1052 on regulatory technical standards for the conditions applicable to buy-back programmes and stabilisation measures. which supplements that Regulation.
Further information please contact Kvika‘s investor relations. [email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Basilea announces start of clinical study by partner Asahi Kasei Therapeutics in Japan with antifungal Cresemba® (isavuconazole) in pediatric patients
- Ackermans & van Haaren publishes convening notice for the Extraordinary Shareholder Meeting of October 15, 2026
- Space42 and Viasat Sign Binding Agreement to co-found Equatys, Creating the First Shared Space and Ground Infrastructure Platform for Global Direct-to-Device and Advanced MSS Connectivity
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Stock BuybackSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share